HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joaquín Castilla Selected Research

Prions

12/2021Biosemiotics comprehension of PrP code and prion disease.
1/2021Prion-Associated Neurodegeneration Causes Both Endoplasmic Reticulum Stress and Proteasome Impairment in a Murine Model of Spontaneous Disease.
1/2020Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases.
1/2020Dogs are resistant to prion infection, due to the presence of aspartic or glutamic acid at position 163 of their prion protein.
10/2019Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies.
9/2019A Single Amino Acid Substitution, Found in Mammals with Low Susceptibility to Prion Diseases, Delays Propagation of Two Prion Strains in Highly Susceptible Transgenic Mouse Models.
8/2019Insights into the Bidirectional Properties of the Sheep-Deer Prion Transmission Barrier.
7/2018An Amino Acid Substitution Found in Animals with Low Susceptibility to Prion Diseases Confers a Protective Dominant-Negative Effect in Prion-Infected Transgenic Mice.
1/2018Behind the potential evolution towards prion resistant species.
12/2017In Vitro Approach To Identify Key Amino Acids in Low Susceptibility of Rabbit Prion Protein to Misfolding.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joaquín Castilla Research Topics

Disease

41Prion Diseases (Transmissible Spongiform Encephalopathies)
12/2021 - 01/2004
17Infections
06/2021 - 05/2004
14Scrapie
12/2021 - 03/2005
13Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 01/2005
10Bovine Spongiform Encephalopathy (Mad Cow Disease)
12/2017 - 05/2004
7Chronic Wasting Disease
08/2019 - 08/2008
4Alzheimer Disease (Alzheimer's Disease)
01/2017 - 01/2013
4Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
04/2015 - 06/2009
3Parkinson Disease (Parkinson's Disease)
01/2018 - 09/2015
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2017 - 01/2013
2Brain Diseases (Brain Disorder)
12/2021 - 01/2015
2Pathologic Processes
12/2021 - 01/2013
2Erythropoietic Porphyria (Congenital Erythropoietic Porphyria)
05/2021 - 01/2018
2Communicable Diseases (Infectious Diseases)
09/2015 - 01/2013
1Gliosis
01/2021
1Autoimmune Diseases (Autoimmune Disease)
10/2020
1Amyloidosis
01/2017
1Amyloid Plaque
09/2015
1Fatal Familial Insomnia
04/2015
1Inborn Genetic Diseases (Disease, Hereditary)
12/2013
1Proteostasis Deficiencies
03/2006
1Neuroblastoma
03/2005
1Asymptomatic Infections
05/2004

Drug/Important Bio-Agent (IBA)

46PrionsIBA
12/2021 - 05/2004
38Prion ProteinsIBA
12/2021 - 05/2004
16Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2005
9Protein Isoforms (Isoforms)IBA
12/2021 - 06/2009
6Amino AcidsFDA Link
01/2020 - 12/2013
5Amyloid (Amyloid Fibrils)IBA
01/2018 - 07/2005
2Biomarkers (Surrogate Marker)IBA
06/2021 - 01/2020
2Endopeptidase K (Proteinase K)IBA
06/2021 - 01/2004
2Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA
05/2021 - 01/2018
2Ciclopirox (Loprox)FDA LinkGeneric
05/2021 - 01/2018
2EnzymesIBA
05/2021 - 01/2018
2Heme (Haem)IBA
05/2021 - 01/2018
2Codon (Codons)IBA
10/2020 - 03/2013
2Biological ProductsIBA
08/2019 - 01/2014
2Methionine (L-Methionine)FDA Link
10/2017 - 03/2013
2Isoleucine (L-Isoleucine)FDA Link
10/2017 - 03/2013
1alpha-SynucleinIBA
12/2021
1tau Proteins (tau Protein)IBA
12/2021
1MicroRNAs (MicroRNA)IBA
06/2021
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2021
1ferric oxide (iron oxide)IBA
01/2021
1Immunoglobulin G (IgG)IBA
10/2020
1AutoantibodiesIBA
10/2020
1Complement System Proteins (Complement)IBA
01/2020
1SolutionsIBA
01/2020
1Glutamic Acid (Glutamate)FDA Link
01/2020
1Pharmaceutical PreparationsIBA
01/2018
1AntigensIBA
05/2017
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
01/2017
1meso- tetrakis(1- methyl- 4- pyridiniumyl)porphyrinIBA
03/2016
1Peptide Hydrolases (Proteases)FDA Link
01/2016
1Protein AggregatesIBA
09/2015
1AA amyloidosisIBA
09/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2007
1LipidsIBA
06/2007
1coenzyme Q10 (CoQ10)IBA
06/2007
1UbiquinoneIBA
06/2007
1AntioxidantsIBA
06/2007
1Small Interfering RNA (siRNA)IBA
03/2005
1PrPSc ProteinsIBA
05/2004

Therapy/Procedure

2Therapeutics
03/2016 - 01/2013
1Cell- and Tissue-Based Therapy (Cell Therapy)
12/2015